| P50 | author | Philippe Talon | Q102250190 |
| P2093 | author name string | Matthieu Eveillard | |
| | Francise Fauvelle | |
| | Laurence Belfayol | |
| | Patrice Alet | |
| P2860 | cites work | Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin | Q28327231 |
| | Determination of optimal dosage regimen for amikacin in healthy volunteers by study of pharmacokinetics and bactericidal activity | Q35252291 |
| | Once versus thrice daily gentamicin in patients with serious infections | Q39369365 |
| | Pharmacokinetic Properties of Netilmicin in Newborn Infants | Q40619982 |
| | Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation | Q40749278 |
| | Aminoglycoside forecasting in neutropenic patients with cancer | Q41092851 |
| | Bayesian forecasting of serum gentamicin concentrations in intensive care patients | Q41192738 |
| | Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe gram-negative infections | Q41962121 |
| | Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group | Q42622242 |
| | Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone | Q43459102 |
| | Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 |
| | Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic gram-negative infections. | Q50544370 |
| | Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin. | Q52522833 |
| | Some suggestions for measuring predictive performance | Q52875851 |
| | Single daily dose amikacin in paediatric patients with severe Gram-negative infections | Q67920887 |
| | Validation of the use of Bayesian analysis in the optimization of gentamicin therapy from the commencement of dosing | Q68287532 |
| | Monitoring serum concentrations for once-daily netilmicin dosing regimens | Q72417285 |
| P433 | issue | 3 | |
| P921 | main subject | pharmacokinetics | Q323936 |
| | amikacin | Q408529 |
| P304 | page(s) | 186-191 | |
| P577 | publication date | 1996-02-01 | |
| P1433 | published in | Clinical Microbiology and Infection | Q15757285 |
| P1476 | title | Pharmacokinetics of once-daily amikacin in pediatric patients | |
| P478 | volume | 2 | |